Esbriet
Chemical Name | pirfenidone |
Dosage Form | Capsule (oral; 267 mg); Tablet (oral; 267 mg, 801 mg) |
Drug Class | Miscellaneous |
System | Respiratory |
Company | Genentech |
Approval Year | 2014 |
Indication
- For the treatment of idiopathic pulmonary fibrosis (IPF).
Chemical Name | pirfenidone |
Dosage Form | Capsule (oral; 267 mg); Tablet (oral; 267 mg, 801 mg) |
Drug Class | Miscellaneous |
System | Respiratory |
Company | Genentech |
Approval Year | 2014 |